New Results
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
View ORCID ProfileJames F. Demarest, Maryline Kienle, RuthMabel Boytz, Mary Ayres, Eun Jung Kim, Donghoon Chung, Varsha Gandhi, View ORCID ProfileRobert Davey, David B. Sykes, Nadim Shohdy, John C. Pottage Jr., View ORCID ProfileVikram S. Kumar
doi: https://doi.org/10.1101/2022.03.30.486499
James F. Demarest
aClear Creek Bio, Cambridge, Massachusetts, USA
Maryline Kienle
aClear Creek Bio, Cambridge, Massachusetts, USA
RuthMabel Boytz
bNEIDL, Boston University, Boston, Massachusetts, USA
Mary Ayres
cDepartment of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA
Eun Jung Kim
dUniversity of Louisville, Louisville, Kentucky, USA
Donghoon Chung
dUniversity of Louisville, Louisville, Kentucky, USA
Varsha Gandhi
cDepartment of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA
Robert Davey
bNEIDL, Boston University, Boston, Massachusetts, USA
David B. Sykes
aClear Creek Bio, Cambridge, Massachusetts, USA
eCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
fHarvard Stem Cell Institute, Cambridge, MA
gMassachusetts General Hospital Cancer Center, Boston, MA
Nadim Shohdy
aClear Creek Bio, Cambridge, Massachusetts, USA
John C. Pottage Jr.
aClear Creek Bio, Cambridge, Massachusetts, USA
Vikram S. Kumar
aClear Creek Bio, Cambridge, Massachusetts, USA
Article usage
Posted April 04, 2022.
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
James F. Demarest, Maryline Kienle, RuthMabel Boytz, Mary Ayres, Eun Jung Kim, Donghoon Chung, Varsha Gandhi, Robert Davey, David B. Sykes, Nadim Shohdy, John C. Pottage Jr., Vikram S. Kumar
bioRxiv 2022.03.30.486499; doi: https://doi.org/10.1101/2022.03.30.486499
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
James F. Demarest, Maryline Kienle, RuthMabel Boytz, Mary Ayres, Eun Jung Kim, Donghoon Chung, Varsha Gandhi, Robert Davey, David B. Sykes, Nadim Shohdy, John C. Pottage Jr., Vikram S. Kumar
bioRxiv 2022.03.30.486499; doi: https://doi.org/10.1101/2022.03.30.486499
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)